866-997-4948(US-Canada Toll Free)

Metastatic Lung Cancer-Pipeline Insights, 2016

Published By :

DelveInsight

Published Date : Jan 2016

Category :

Cancer

No. of Pages : 60 Pages

SUMMARY
DelveInsights, Metastatic Lung Cancer-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Metastatic Lung Cancer. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsights Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Metastatic Lung Cancer. DelveInsights Report also assesses the Metastatic Lung Cancer therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Scope

Table of Contents
Metastatic Lung Cancer Overview
Metastatic Lung Cancer Pipeline Therapeutics
Metastatic Lung Cancer Therapeutics under Development by Companies
Metastatic Lung Cancer Filed and Phase III Products
Comparative Analysis
Metastatic Lung Cancer Phase II Products
Comparative Analysis
Metastatic Lung Cancer Phase I and IND Filed Products
Comparative Analysis
Metastatic Lung Cancer Discovery and Pre-Clinical Stage Products
Comparative Analysis
Drug Candidate Profiles
Metastatic Lung Cancer Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Metastatic Lung Cancer Discontinued Products
Metastatic Lung Cancer Dormant Products
Companies Involved in Therapeutics Development for Metastatic Lung Cancer
Appendix
Methodology
Contact Us
Disclaimer

List of Table

List of Tables
Number of Products under Development for Metastatic Lung Cancer, 2016
Number of Products under Development by Companies
Comparative Analysis by Filed and Phase III Products, 2016
Comparative Analysis Phase II Products, 2016
Comparative Analysis Phase I and IND Filed Products, 2016
Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
Drug Candidates Profiles
Metastatic Lung Cancer Assessment by Monotherapy Products
Metastatic Lung Cancer Assessment by Combination Products
Metastatic Lung Cancer Assessment by Route of Administration
Metastatic Lung Cancer Assessment by Stage and Route of Administration
Metastatic Lung Cancer Assessment by Molecule Type
Metastatic Lung Cancer Assessment by Stage and Molecule Type
Metastatic Lung Cancer Therapeutics Discontinued Products
Metastatic Lung Cancer Therapeutics Dormant Products
Products under Development by Companies, 2016

List of Chart

List of Figures
Number of Products under Development for Metastatic Lung Cancer, 2016
Filed and Phase III Products, 2016
Phase II Products, 2016
Phase I and IND Filed Products, 2016
Discovery and Pre-Clinical Stage Products, 2016
Metastatic Lung Cancer Assessment by Monotherapy Products
Metastatic Lung Cancer Assessment by Combination Products
Metastatic Lung Cancer Assessment by Route of Administration
Metastatic Lung Cancer Assessment by Stage and Route of Administration
Metastatic Lung Cancer Assessment by Molecule Type
Metastatic Lung Cancer Assessment by Stage and Molecule Type

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *